{
  "study_id": "NCT00724503",
  "study_title": "SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal Cancer",
  "table_name": "Table 1",
  "table_title": "Baseline Patient and Disease Characteristics (ITT Population)",
  "description": "Baseline characteristics for the Intent-to-Treat (ITT) population.",
  "footnotes": [
    "Data are presented as No. (%) unless indicated otherwise.",
    "Abbreviations: bev, bevacizumab; ITT, intent to treat; mFOLFOX6, modified fluorouracil, leucovorin, and oxaliplatin; SIRT, selective internal radiation therapy.",
    "Unknown for one patient: patient withdrew consent and records."
  ],
  "groups": [
    {
      "name": "Control Arm (mFOLFOX6 [± bev])",
      "n": 263,
      "type": "control"
    },
    {
      "name": "Treatment Arm (SIRT + mFOLFOX6 [± bev])",
      "n": 267,
      "type": "intervention"
    }
  ],
  "characteristics": [
    {
      "original_label": "Age, years, median (range)",
      "standardized_name": "age",
      "unit": "years",
      "category": "Demographics",
      "time_point": "Baseline",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "Control Arm (mFOLFOX6 [± bev])",
          "data_type": "numeric_median_iqr",
          "median": 63.0,
          "iqr_min": 23.0,
          "iqr_max": 89.0,
          "raw_string": "63 (23-89)",
          "n_for_value": 263
        },
        {
          "group_name": "Treatment Arm (SIRT + mFOLFOX6 [± bev])",
          "data_type": "numeric_median_iqr",
          "median": 63.0,
          "iqr_min": 28.0,
          "iqr_max": 81.0,
          "raw_string": "63 (28-81)",
          "n_for_value": 267
        }
      ]
    },
    {
      "original_label": "Sex",
      "standardized_name": "sex",
      "category": "Demographics",
      "time_point": "Baseline",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "Control Arm (mFOLFOX6 [± bev])",
          "data_type": "header",
          "raw_string": "Sex"
        },
        {
          "group_name": "Treatment Arm (SIRT + mFOLFOX6 [± bev])",
          "data_type": "header",
          "raw_string": "Sex"
        }
      ]
    },
    {
      "original_label": "Male",
      "standardized_name": "sex",
      "category": "Demographics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Sex",
      "group_data": [
        {
          "group_name": "Control Arm (mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 174.0,
          "percentage": 66.2,
          "raw_string": "174 (66.2)*",
          "n_for_value": 262
        },
        {
          "group_name": "Treatment Arm (SIRT + mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 182.0,
          "percentage": 68.2,
          "raw_string": "182 (68.2)",
          "n_for_value": 267
        }
      ]
    },
    {
      "original_label": "Female",
      "standardized_name": "sex",
      "category": "Demographics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Sex",
      "group_data": [
        {
          "group_name": "Control Arm (mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 88.0,
          "percentage": 33.5,
          "raw_string": "88 (33.5)",
          "n_for_value": 262
        },
        {
          "group_name": "Treatment Arm (SIRT + mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 85.0,
          "percentage": 31.8,
          "raw_string": "85 (31.8)",
          "n_for_value": 267
        }
      ]
    },
    {
      "original_label": "Race",
      "standardized_name": "race",
      "category": "Demographics",
      "time_point": "Baseline",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "Control Arm (mFOLFOX6 [± bev])",
          "data_type": "header",
          "raw_string": "Race"
        },
        {
          "group_name": "Treatment Arm (SIRT + mFOLFOX6 [± bev])",
          "data_type": "header",
          "raw_string": "Race"
        }
      ]
    },
    {
      "original_label": "White",
      "standardized_name": "race",
      "category": "Demographics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Race",
      "group_data": [
        {
          "group_name": "Control Arm (mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 243.0,
          "percentage": 92.4,
          "raw_string": "243 (92.4)",
          "n_for_value": 263
        },
        {
          "group_name": "Treatment Arm (SIRT + mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 248.0,
          "percentage": 92.9,
          "raw_string": "248 (92.9)",
          "n_for_value": 267
        }
      ]
    },
    {
      "original_label": "Black",
      "standardized_name": "race",
      "category": "Demographics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Race",
      "group_data": [
        {
          "group_name": "Control Arm (mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 8.0,
          "percentage": 3.0,
          "raw_string": "8 (3.0)",
          "n_for_value": 263
        },
        {
          "group_name": "Treatment Arm (SIRT + mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 2.0,
          "percentage": 0.7,
          "raw_string": "2 (0.7)",
          "n_for_value": 267
        }
      ]
    },
    {
      "original_label": "Other",
      "standardized_name": "race",
      "category": "Demographics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Race",
      "group_data": [
        {
          "group_name": "Control Arm (mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 7.0,
          "percentage": 2.7,
          "raw_string": "7 (2.7)",
          "n_for_value": 263
        },
        {
          "group_name": "Treatment Arm (SIRT + mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 11.0,
          "percentage": 4.1,
          "raw_string": "11 (4.1)",
          "n_for_value": 267
        }
      ]
    },
    {
      "original_label": "Unknown",
      "standardized_name": "race",
      "category": "Demographics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Race",
      "group_data": [
        {
          "group_name": "Control Arm (mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 5.0,
          "percentage": 1.9,
          "raw_string": "5 (1.9)",
          "n_for_value": 263
        },
        {
          "group_name": "Treatment Arm (SIRT + mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 6.0,
          "percentage": 2.2,
          "raw_string": "6 (2.2)",
          "n_for_value": 267
        }
      ]
    },
    {
      "original_label": "WHO performance status",
      "standardized_name": "who_performance_status",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "Control Arm (mFOLFOX6 [± bev])",
          "data_type": "header",
          "raw_string": "WHO performance status"
        },
        {
          "group_name": "Treatment Arm (SIRT + mFOLFOX6 [± bev])",
          "data_type": "header",
          "raw_string": "WHO performance status"
        }
      ]
    },
    {
      "original_label": "0",
      "standardized_name": "who_performance_status",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "WHO performance status",
      "group_data": [
        {
          "group_name": "Control Arm (mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 175.0,
          "percentage": 66.5,
          "raw_string": "175 (66.5)",
          "n_for_value": 263
        },
        {
          "group_name": "Treatment Arm (SIRT + mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 176.0,
          "percentage": 65.9,
          "raw_string": "176 (65.9)",
          "n_for_value": 267
        }
      ]
    },
    {
      "original_label": "1",
      "standardized_name": "who_performance_status",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "WHO performance status",
      "group_data": [
        {
          "group_name": "Control Arm (mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 87.0,
          "percentage": 33.1,
          "raw_string": "87 (33.1)*",
          "n_for_value": 262
        },
        {
          "group_name": "Treatment Arm (SIRT + mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 90.0,
          "percentage": 33.7,
          "raw_string": "90 (33.7)*",
          "n_for_value": 266
        }
      ]
    },
    {
      "original_label": "Extrahepatic metastases at randomization",
      "standardized_name": "extrahepatic_metastases_at_randomization",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "Control Arm (mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 104.0,
          "percentage": 39.5,
          "raw_string": "104 (39.5)",
          "n_for_value": 263
        },
        {
          "group_name": "Treatment Arm (SIRT + mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 108.0,
          "percentage": 40.4,
          "raw_string": "108 (40.4)",
          "n_for_value": 267
        }
      ]
    },
    {
      "original_label": "Lungs alone",
      "standardized_name": "extrahepatic_metastases_location",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Extrahepatic metastases at randomization",
      "group_data": [
        {
          "group_name": "Control Arm (mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 36.0,
          "percentage": 34.6,
          "raw_string": "36 (34.6)",
          "n_for_value": 104
        },
        {
          "group_name": "Treatment Arm (SIRT + mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 41.0,
          "percentage": 38.0,
          "raw_string": "41 (38.0)",
          "n_for_value": 108
        }
      ]
    },
    {
      "original_label": "Lungs and lymph nodes",
      "standardized_name": "extrahepatic_metastases_location",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Extrahepatic metastases at randomization",
      "group_data": [
        {
          "group_name": "Control Arm (mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 18.0,
          "percentage": 17.3,
          "raw_string": "18 (17.3)",
          "n_for_value": 104
        },
        {
          "group_name": "Treatment Arm (SIRT + mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 14.0,
          "percentage": 13.0,
          "raw_string": "14 (13.0)",
          "n_for_value": 108
        }
      ]
    },
    {
      "original_label": "Lymph nodes alone",
      "standardized_name": "extrahepatic_metastases_location",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Extrahepatic metastases at randomization",
      "group_data": [
        {
          "group_name": "Control Arm (mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 48.0,
          "percentage": 46.2,
          "raw_string": "48 (46.2)",
          "n_for_value": 104
        },
        {
          "group_name": "Treatment Arm (SIRT + mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 47.0,
          "percentage": 43.5,
          "raw_string": "47 (43.5)",
          "n_for_value": 108
        }
      ]
    },
    {
      "original_label": "Unspecified",
      "standardized_name": "extrahepatic_metastases_location",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Extrahepatic metastases at randomization",
      "group_data": [
        {
          "group_name": "Control Arm (mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 2.0,
          "percentage": 1.9,
          "raw_string": "2 (1.9)",
          "n_for_value": 104
        },
        {
          "group_name": "Treatment Arm (SIRT + mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 6.0,
          "percentage": 5.6,
          "raw_string": "6 (5.6)",
          "n_for_value": 108
        }
      ]
    },
    {
      "original_label": "Primary tumor in situ",
      "standardized_name": "primary_tumor_in_situ",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "Control Arm (mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 121.0,
          "percentage": 46.0,
          "raw_string": "121 (46.0)*",
          "n_for_value": 262
        },
        {
          "group_name": "Treatment Arm (SIRT + mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 119.0,
          "percentage": 44.6,
          "raw_string": "119 (44.6)",
          "n_for_value": 267
        }
      ]
    },
    {
      "original_label": "Primary tumor location",
      "standardized_name": "primary_tumor_location",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "Control Arm (mFOLFOX6 [± bev])",
          "data_type": "header",
          "raw_string": "Primary tumor location"
        },
        {
          "group_name": "Treatment Arm (SIRT + mFOLFOX6 [± bev])",
          "data_type": "header",
          "raw_string": "Primary tumor location"
        }
      ]
    },
    {
      "original_label": "Left",
      "standardized_name": "primary_tumor_location",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Primary tumor location",
      "group_data": [
        {
          "group_name": "Control Arm (mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 137.0,
          "percentage": 52.1,
          "raw_string": "137 (52.1)",
          "n_for_value": 263
        },
        {
          "group_name": "Treatment Arm (SIRT + mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 141.0,
          "percentage": 52.8,
          "raw_string": "141 (52.8)",
          "n_for_value": 267
        }
      ]
    },
    {
      "original_label": "Right",
      "standardized_name": "primary_tumor_location",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Primary tumor location",
      "group_data": [
        {
          "group_name": "Control Arm (mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 55.0,
          "percentage": 20.1,
          "raw_string": "55 (20.1)",
          "n_for_value": 263
        },
        {
          "group_name": "Treatment Arm (SIRT + mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 72.0,
          "percentage": 27.0,
          "raw_string": "72 (27.0)",
          "n_for_value": 267
        }
      ]
    },
    {
      "original_label": "Rectal",
      "standardized_name": "primary_tumor_location",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Primary tumor location",
      "group_data": [
        {
          "group_name": "Control Arm (mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 59.0,
          "percentage": 22.4,
          "raw_string": "59 (22.4)",
          "n_for_value": 263
        },
        {
          "group_name": "Treatment Arm (SIRT + mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 45.0,
          "percentage": 16.9,
          "raw_string": "45 (16.9)",
          "n_for_value": 267
        }
      ]
    },
    {
      "original_label": "Left + right",
      "standardized_name": "primary_tumor_location",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Primary tumor location",
      "group_data": [
        {
          "group_name": "Control Arm (mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 4.0,
          "percentage": 1.5,
          "raw_string": "4 (1.5)",
          "n_for_value": 263
        },
        {
          "group_name": "Treatment Arm (SIRT + mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 5.0,
          "percentage": 1.9,
          "raw_string": "5 (1.9)",
          "n_for_value": 267
        }
      ]
    },
    {
      "original_label": "Left + rectal",
      "standardized_name": "primary_tumor_location",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Primary tumor location",
      "group_data": [
        {
          "group_name": "Control Arm (mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 4.0,
          "percentage": 1.5,
          "raw_string": "4 (1.5)",
          "n_for_value": 263
        },
        {
          "group_name": "Treatment Arm (SIRT + mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 2.0,
          "percentage": 0.7,
          "raw_string": "2 (0.7)",
          "n_for_value": 267
        }
      ]
    },
    {
      "original_label": "Left + right + rectal",
      "standardized_name": "primary_tumor_location",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Primary tumor location",
      "group_data": [
        {
          "group_name": "Control Arm (mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 2.0,
          "percentage": 0.8,
          "raw_string": "2 (0.8)",
          "n_for_value": 263
        },
        {
          "group_name": "Treatment Arm (SIRT + mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 0.0,
          "percentage": 0.0,
          "raw_string": "0 (0.0)",
          "n_for_value": 267
        }
      ]
    },
    {
      "original_label": "Unknown",
      "standardized_name": "primary_tumor_location",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Primary tumor location",
      "group_data": [
        {
          "group_name": "Control Arm (mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 2.0,
          "percentage": 0.8,
          "raw_string": "2 (0.8)",
          "n_for_value": 263
        },
        {
          "group_name": "Treatment Arm (SIRT + mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 2.0,
          "percentage": 0.7,
          "raw_string": "2 (0.7)",
          "n_for_value": 267
        }
      ]
    },
    {
      "original_label": "Synchronous metastases",
      "standardized_name": "synchronous_metastases",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "Control Arm (mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 233.0,
          "percentage": 88.6,
          "raw_string": "233 (88.6)",
          "n_for_value": 263
        },
        {
          "group_name": "Treatment Arm (SIRT + mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 241.0,
          "percentage": 90.3,
          "raw_string": "241 (90.3)",
          "n_for_value": 267
        }
      ]
    },
    {
      "original_label": "Tumor liver involvement, %",
      "standardized_name": "tumor_liver_involvement",
      "unit": "%",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "Control Arm (mFOLFOX6 [± bev])",
          "data_type": "header",
          "raw_string": "Tumor liver involvement, %"
        },
        {
          "group_name": "Treatment Arm (SIRT + mFOLFOX6 [± bev])",
          "data_type": "header",
          "raw_string": "Tumor liver involvement, %"
        }
      ]
    },
    {
      "original_label": "≤ 25",
      "standardized_name": "tumor_liver_involvement",
      "unit": "%",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Tumor liver involvement, %",
      "group_data": [
        {
          "group_name": "Control Arm (mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 192.0,
          "percentage": 73.0,
          "raw_string": "192 (73.0)",
          "n_for_value": 262
        },
        {
          "group_name": "Treatment Arm (SIRT + mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 185.0,
          "percentage": 69.3,
          "raw_string": "185 (69.3)",
          "n_for_value": 266
        }
      ]
    },
    {
      "original_label": "> 25",
      "standardized_name": "tumor_liver_involvement",
      "unit": "%",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Tumor liver involvement, %",
      "group_data": [
        {
          "group_name": "Control Arm (mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 70.0,
          "percentage": 26.6,
          "raw_string": "70 (26.6)*",
          "n_for_value": 262
        },
        {
          "group_name": "Treatment Arm (SIRT + mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 81.0,
          "percentage": 30.3,
          "raw_string": "81 (30.3)*",
          "n_for_value": 266
        }
      ]
    },
    {
      "original_label": "Prior adjuvant chemotherapy",
      "standardized_name": "prior_adjuvant_chemotherapy",
      "category": "Prior Treatment",
      "time_point": "Baseline",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "Control Arm (mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 16.0,
          "percentage": 6.1,
          "raw_string": "16 (6.1)",
          "n_for_value": 263
        },
        {
          "group_name": "Treatment Arm (SIRT + mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 13.0,
          "percentage": 4.9,
          "raw_string": "13 (4.9)",
          "n_for_value": 267
        }
      ]
    },
    {
      "original_label": "Prior radiotherapy to nonliver sites",
      "standardized_name": "prior_radiotherapy_to_nonliver_sites",
      "category": "Prior Treatment",
      "time_point": "Baseline",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "Control Arm (mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 14.0,
          "percentage": 5.3,
          "raw_string": "14 (5.3)",
          "n_for_value": 263
        },
        {
          "group_name": "Treatment Arm (SIRT + mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 11.0,
          "percentage": 4.1,
          "raw_string": "11 (4.1)",
          "n_for_value": 267
        }
      ]
    },
    {
      "original_label": "Reasons for unresectability of liver metastases",
      "standardized_name": "reason_for_unresectability_of_liver_metastases",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "Control Arm (mFOLFOX6 [± bev])",
          "data_type": "header",
          "raw_string": "Reasons for unresectability of liver metastases"
        },
        {
          "group_name": "Treatment Arm (SIRT + mFOLFOX6 [± bev])",
          "data_type": "header",
          "raw_string": "Reasons for unresectability of liver metastases"
        }
      ]
    },
    {
      "original_label": "Extrahepatic disease",
      "standardized_name": "reason_for_unresectability",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Reasons for unresectability of liver metastases",
      "group_data": [
        {
          "group_name": "Control Arm (mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 28.0,
          "percentage": 10.6,
          "raw_string": "28 (10.6)",
          "n_for_value": 263
        },
        {
          "group_name": "Treatment Arm (SIRT + mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 33.0,
          "percentage": 12.4,
          "raw_string": "33 (12.4)",
          "n_for_value": 267
        }
      ]
    },
    {
      "original_label": "Insufficient liver reserve",
      "standardized_name": "reason_for_unresectability",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Reasons for unresectability of liver metastases",
      "group_data": [
        {
          "group_name": "Control Arm (mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 19.0,
          "percentage": 7.2,
          "raw_string": "19 (7.2)",
          "n_for_value": 263
        },
        {
          "group_name": "Treatment Arm (SIRT + mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 21.0,
          "percentage": 7.9,
          "raw_string": "21 (7.9)",
          "n_for_value": 267
        }
      ]
    },
    {
      "original_label": "Proximity to major vessels",
      "standardized_name": "reason_for_unresectability",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Reasons for unresectability of liver metastases",
      "group_data": [
        {
          "group_name": "Control Arm (mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 14.0,
          "percentage": 5.3,
          "raw_string": "14 (5.3)",
          "n_for_value": 263
        },
        {
          "group_name": "Treatment Arm (SIRT + mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 13.0,
          "percentage": 4.9,
          "raw_string": "13 (4.9)",
          "n_for_value": 267
        }
      ]
    },
    {
      "original_label": "Medically inoperable",
      "standardized_name": "reason_for_unresectability",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Reasons for unresectability of liver metastases",
      "group_data": [
        {
          "group_name": "Control Arm (mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 32.0,
          "percentage": 12.2,
          "raw_string": "32 (12.2)",
          "n_for_value": 263
        },
        {
          "group_name": "Treatment Arm (SIRT + mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 46.0,
          "percentage": 17.2,
          "raw_string": "46 (17.2)",
          "n_for_value": 267
        }
      ]
    },
    {
      "original_label": "Patient age",
      "standardized_name": "reason_for_unresectability",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Reasons for unresectability of liver metastases",
      "group_data": [
        {
          "group_name": "Control Arm (mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 7.0,
          "percentage": 2.7,
          "raw_string": "7 (2.7)",
          "n_for_value": 263
        },
        {
          "group_name": "Treatment Arm (SIRT + mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 3.0,
          "percentage": 1.1,
          "raw_string": "3 (1.1)",
          "n_for_value": 267
        }
      ]
    },
    {
      "original_label": "Tumor too large",
      "standardized_name": "reason_for_unresectability",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Reasons for unresectability of liver metastases",
      "group_data": [
        {
          "group_name": "Control Arm (mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 43.0,
          "percentage": 16.3,
          "raw_string": "43 (16.3)",
          "n_for_value": 263
        },
        {
          "group_name": "Treatment Arm (SIRT + mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 49.0,
          "percentage": 18.4,
          "raw_string": "49 (18.4)",
          "n_for_value": 267
        }
      ]
    },
    {
      "original_label": "Too many tumors",
      "standardized_name": "reason_for_unresectability",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Reasons for unresectability of liver metastases",
      "group_data": [
        {
          "group_name": "Control Arm (mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 199.0,
          "percentage": 75.7,
          "raw_string": "199 (75.7)",
          "n_for_value": 263
        },
        {
          "group_name": "Treatment Arm (SIRT + mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 197.0,
          "percentage": 73.8,
          "raw_string": "197 (73.8)",
          "n_for_value": 267
        }
      ]
    },
    {
      "original_label": "Attachment to another major structure",
      "standardized_name": "reason_for_unresectability",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Reasons for unresectability of liver metastases",
      "group_data": [
        {
          "group_name": "Control Arm (mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 1.0,
          "percentage": 0.4,
          "raw_string": "1 (0.4)",
          "n_for_value": 263
        },
        {
          "group_name": "Treatment Arm (SIRT + mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 1.0,
          "percentage": 0.4,
          "raw_string": "1 (0.4)",
          "n_for_value": 267
        }
      ]
    },
    {
      "original_label": "Other",
      "standardized_name": "reason_for_unresectability",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Reasons for unresectability of liver metastases",
      "group_data": [
        {
          "group_name": "Control Arm (mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 9.0,
          "percentage": 3.4,
          "raw_string": "9 (3.4)",
          "n_for_value": 263
        },
        {
          "group_name": "Treatment Arm (SIRT + mFOLFOX6 [± bev])",
          "data_type": "categorical_count_percentage",
          "count": 10.0,
          "percentage": 3.7,
          "raw_string": "10 (3.7)",
          "n_for_value": 267
        }
      ]
    }
  ]
}